These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5386785)

  • 21. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1971 Jan; 78(1):1-16. PubMed ID: 5539083
    [No Abstract]   [Full Text] [Related]  

  • 22. Measles antibody in previously immunized children. The need for revaccination.
    Linnemann CC; Dine MS; Bloom JE; Schiff GM
    Am J Dis Child; 1972 Jul; 124(1):53-7. PubMed ID: 5033750
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of delayed dermal hypersensitivity in patients with subacute sclerosing panencephalitis.
    Jabbour JT; Roane JA; Sever JL
    Neurology; 1969 Oct; 19(10):929-31. PubMed ID: 5387707
    [No Abstract]   [Full Text] [Related]  

  • 26. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of association between HL-A antigens and measles antibody in multiple sclerosis.
    Bertrams J; von Fisenne E; Hoher PG; Kuwert E
    Lancet; 1973 Aug; 2(7826):441. PubMed ID: 4124913
    [No Abstract]   [Full Text] [Related]  

  • 28. Measles antibodies in the serum and cerebrospinal fluid in subacute sclerosing panencephalitis.
    Kipps A; Naudé Wdu T; Smith T; MacKenzie DJ; McDonald R
    S Afr Med J; 1974 Jan; 48(1):10-2. PubMed ID: 4814481
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 30. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
    BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
    J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis.
    Payne FE; Baublis JV; Itabashi HH
    N Engl J Med; 1969 Sep; 281(11):585-9. PubMed ID: 4980073
    [No Abstract]   [Full Text] [Related]  

  • 32. The clinical spectrum and early diagnosis of Dawson's encephalitis, with preliminary notes on treatment.
    Freeman JM
    J Pediatr; 1969 Oct; 75(4):590-603. PubMed ID: 4185707
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibodies to measles, mumps, and herpes simplex virus in cerebrospinal fluid in acute infections and postinfectious diseases of the central nervous system.
    Winchester JS; Hambling MH
    J Med Microbiol; 1972 Feb; 5(1):137-43. PubMed ID: 5022506
    [No Abstract]   [Full Text] [Related]  

  • 35. [Measles and titers of measles antibodies in the cerebrospinal fluid and blood in children with chronic diseases of the central nervous system].
    Kaciński M
    Pediatr Pol; 1981; 56(11-12):1297-301. PubMed ID: 7339556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of enzyme-linked immunosorbent assay for acute measles with hemagglutination inhibition complement fixation, and fluorescent-antibody methods.
    Kleiman MB; Blackburn CK; Zimmerman SE; French ML
    J Clin Microbiol; 1981 Aug; 14(2):147-52. PubMed ID: 7024302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation of a commercially available indirect fluorescent antibody slide test for measuring measles-specific immunoglobulins.
    Kleiman MB; Bockhold CA; Zimmerman SE; Griffin C; French ML; Barrett C
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):285-90. PubMed ID: 3516550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 40. Measles virus specific precipitins in sera from patients with chronic active hepatitis.
    Christie KE; Haukenes G
    Scand J Infect Dis; 1979; 11(2):99-106. PubMed ID: 462137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.